Saratoga Research & Investment Management
Q1 2014 13F-HR Holdings
Net value change ($000)
+42,151
(4.5%)
New positions
2
Sold out positions
3
Turnover %
0.7%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2013
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| NVO | 7,793 | 25.7% |
| MSFT | 6,715 | 13.9% |
| ORCL | 5,174 | 10.5% |
| Medtronic PLC | 4,128 | 9.7% |
| BDX | 3,550 | 9.5% |
| IBM | 3,409 | 9.6% |
| BAX | 2,705 | NEW |
| MCD | 2,653 | 7.2% |
| VARIAN MEDICAL SYSTEMS INC | 2,623 | 13.6% |
| EXPD | 2,387 | NEW |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|